From the Journals

Telomere length linked to COPD exacerbations, mortality

Publish date: August 7, 2018

 

FROM CHEST

SOURCE: Jin M et al. Chest. 2018 Jul 12. doi: 10.1016/j.chest.2018.05.022.

Pages

Recommended Reading

Most COPD patients on triple therapy can withdraw steroids
MDedge Internal Medicine
COPD patient subset gains no benefit from low-dose theophylline
MDedge Internal Medicine
AZD8871 delivered significant bronchodilation in two-week study
MDedge Internal Medicine
Education sessions upped COPD patients’ knowledge of their disease
MDedge Internal Medicine
Aclidinium bromide for COPD: No impact on MACE
MDedge Internal Medicine
Lung volume reduction procedures on the rise since 2011
MDedge Internal Medicine
Noninvasive ventilation during exercise benefited a subgroup of COPD patients
MDedge Internal Medicine
Medicare’s bundled pay plan didn’t deliver big cost savings
MDedge Internal Medicine
Ten tips for managing patients with both heart failure and COPD
MDedge Internal Medicine
FDA rejects mepolizumab on efficacy, but supports safety for COPD
MDedge Internal Medicine